+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Rx/Reimbursement Adult Incontinence in Switzerland

  • PDF Icon

    Report

  • 19 Pages
  • March 2024
  • Region: Switzerland
  • Euromonitor International
  • ID: 4517585
An ageing population in need of constant care is driving growth of Rx/reimbursement adult incontinence products in Switzerland among both elderly and temporary post-partum incontinence sufferers. Many Swiss consumers are visiting their doctors more frequently in 2023, in an attempt to save some money by obtaining prescriptions for incontinence products. Value growth was partly driven by the increased costs of production and effects of a high inflation rate on prices.

The Rx/Reimbursement adult incontinence in Switzerland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2028 illustrate how the market is set to change.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Rx/Reimbursement adult incontinence market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

RX/REIMBURSEMENT ADULT INCONTINENCE IN SWITZERLANDKEY DATA FINDINGS
2023 DEVELOPMENTS
  • Demand strengthens in 2023
  • Growing acceptance of adult incontinence supports sales development
  • Product development closely related to moderate/heavy adult incontinence
PROSPECTS AND OPPORTUNITIES
  • Ageing population and reduction in stigma associated with incontinence to fuel demand
  • Consumers likely to seek appropriate guidance during the forecast period, boosting sales
  • Price sensitivity set to support sales over the forecast period
CATEGORY DATA
  • Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2018-2023
  • Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2018-2023
  • Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2023-2028
  • Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2023-2028
TISSUE AND HYGIENE IN SWITZERLAND
EXECUTIVE SUMMARY
  • Tissue and hygiene in 2023: The big picture
  • 2023 key trends
  • Competitive landscape
  • Retailing developments
  • What next for tissue and hygiene?
MARKET INDICATORS
  • Table 5 Birth Rates 2018-2023
  • Table 6 Infant Population 2018-2023
  • Table 7 Female Population by Age 2018-2023
  • Table 8 Total Population by Age 2018-2023
  • Table 9 Households 2018-2023
  • Table 10 Forecast Infant Population 2023-2028
  • Table 11 Forecast Female Population by Age 2023-2028
  • Table 12 Forecast Total Population by Age 2023-2028
  • Table 13 Forecast Households 2023-2028
MARKET DATA
  • Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2018-2023
  • Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2018-2023
  • Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2019-2023
  • Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2020-2023
  • Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2018-2023
  • Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2018-2023
  • Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2023
  • Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2023-2028
  • Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2023-2028
DISCLAIMER
SOURCES
  • Summary 1 Research Sources